
Prologis, Teledyne Technologies, Ascendis Pharma A/S, Canopy Growth, and Hamilton Lane are the five Growth stocks to watch today, according to MarketBeat’s stock screener tool. Growth stocks are shares of companies whose earnings and revenue are expected to grow faster than the overall market, often due to innovation, expanding market share, or scalable business models. Investors buy them primarily for capital appreciation rather than dividends; they typically trade at higher valuation multiples and can be more volatile and risky than value or income stocks. These companies had the highest dollar trading volume of any Growth stocks within the last several days.
Prologis (PLD)
Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.
Teledyne Technologies (TDY)
Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.
Read Our Latest Research Report on TDY
Ascendis Pharma A/S (ASND)
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.
Read Our Latest Research Report on ASND
Canopy Growth (CGC)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Read Our Latest Research Report on CGC
Hamilton Lane (HLNE)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Read Our Latest Research Report on HLNE
Featured Articles
- MarketBeat’s Top Five Stocks to Own in November 2025
- An Earnings Win With a Stock Slump: What’s Happening With D-Wave?
- 3 Stocks Showing Relative Strength as Markets Pull Back
- 5 Defensive Consumer Plays to Watch If Markets Keep Slipping
- Analysts Keep Raving Over AppLovin: Targets Rise Post-Earnings
- Utz Insiders Signal Value With November Buys
